Collaborate to Innovate - #DIA2012 June 24-28 Philadelphia

4 Days. 22 Tracks. 270+ Educational Offerings. 500+ Exhibitors. 7,500+ Attendees. The DIA 2012 48th Annual Meeting offers the most comprehensive and robust learning and networking opportunities to help you find solutions to the challenges you face in the discovery, development, and life cycle management of biopharmaceuticals, biotechnology, medical devices, and related products. Top biopharmaceutical thought leaders will be at the DIA 2012 Annual Meeting to pass on their expertise directly to you. Life Science Entrepreneur Pavilion Network with Entrepreneurs in this year’s new Life Science Entrepreneur Pavilion and discuss how they are changing the future development of new medicines. Pfizer is pleased to support the Life Science Entrepreneur Pavilion at this year’s DIA 2012 Annual Meeting. Funding Funding Innovation and Creating Opportunities in the Device, Diagnostic, and Drug Interface Partnering Models-Public Private Partnerships Pre-competitive Public Private Partnerships: The Changing Model of Pharmaceutical R&D How Industry Can Partner with FDA in Defining a Risk-based Monitoring Program Multistakeholder Development Partnerships: Harnessing Differing Perspectives, Objectives, and Strengths for Success Vaccines Vaccines: FDA and Japan Perspectives Integrated Partnership: A Vaccine Case Study Biotech First-in-human Challenges of Biologics and Biosimilars Product Candidate to Proof-of-concept: An Integrated Approach to Accelerate Programs Regulatory Affairs for Biologics Biomarker Focused Strategies for Personalized Medicine Understanding Comparative Effectiveness Research (CER) in the Biopharmaceutical Industry Other Special Topics Analysis and Impact of PDUFA V: How the Changes Will Affect the Work of Regulatory Affairs Professionals Pediatric Development in the US: Implementation of 2007 PREA and BPCA Against a Backdrop of the EU Pediatric Legislation CBER Town Hall CDER Town Hall: Part 1 of 2 CDER Town Hall: Part 2 of 2 Regulatory Roundtable on Biosimilars Update on Biosimilar Developments in the US Emerging Development and Policy Trends in the Economics of the Biopharmaceutical Industry Risks to and Securing of Global Drug Supply Chains Partnering for Impact in Global Health Executive Program: Pioneering Partnerships Much more! Register Online | Program Overview Group Discounts Available! Register 10 individuals from your company and receive the 11th FREE! Contact your group discount representative for details!

My DIA |

800 Enterprise Road, Suite 200
Horsham, Pennsylvania 19044-3595
T. +1.215.442.6100
F. +1.215.442.6199email: annualmeetingprogram@diahome.org